Reproductive Health in Individuals with Homozygous Beta-thalassemia: Knowledge, Attitudes, and Behavior
Overview
Affiliations
Objective: To review the reproductive health knowledge, attitudes, and behaviors of persons with homozygous beta-thalassemia.
Design: Case-control study.
Setting: Patients treated at a tertiary hospital and community-based healthy controls.
Participant(s): One hundred and thirty persons, 16 years of age or older, who had homozygous beta-thalassemia and were attending hospital for regular blood transfusion, and 99 demographically matched persons without thalassemia. ASSESSMENT TOOL: Reproductive health questionnaire.
Result(s): 104 (80%) persons with homozygous beta-thalassemia completed the questionnaire and were compared with 99 controls. Persons with homozygous beta-thalassemia were as likely as healthy peers to be in a relationship, employed full-time, sexually active, and using contraception and to have had children. Hypogonadotrophic hypogonadism was present in 55 (52.8%) patients, 46 (83.6%) of whom were compliant with hormone replacement therapy. Understanding of genetics and reproductive potential was suboptimal among persons with homozygous beta-thalassemia, and this group had a higher rate of unplanned pregnancy.
Conclusion(s): This study suggests that with optimal therapy, most young adults with homozygous beta-thalassemia can achieve reproductive, sexual, and social experiences similar to those of their healthy peers.
Homozygous Delta-Beta Thalassaemia With Alpha Thalassaemia and Erythrocytosis- a Rare Case Report.
Shokr H, Marwah M, Siddiqi H, Wright C, Marwah S Br J Biomed Sci. 2024; 81:13663.
PMID: 39640193 PMC: 11617142. DOI: 10.3389/bjbs.2024.13663.
Di Maio S, Marzuillo P, Daar S, Kattamis C, Karimi M, Forough S Mediterr J Hematol Infect Dis. 2023; 15(1):e2023058.
PMID: 38028391 PMC: 10631706. DOI: 10.4084/MJHID.2023.058.
Matthiesson H, Berdoukas V, Briganti E Matern Child Health J. 2023; 27(11):1961-1967.
PMID: 37273135 PMC: 10564654. DOI: 10.1007/s10995-023-03683-8.
Fetal factors disrupt placental and maternal iron homeostasis in murine β-thalassemia.
Yu Y, Woloshun R, Lee J, Ebea P, Zhu S, Nemeth E Blood. 2023; 142(2):185-196.
PMID: 37146247 PMC: 10352602. DOI: 10.1182/blood.2022018839.
Mamsen L, Kristensen S, Pors S, Botkjaer J, Ernst E, Macklon K Front Endocrinol (Lausanne). 2021; 11:593718.
PMID: 33519708 PMC: 7844814. DOI: 10.3389/fendo.2020.593718.